Rosalia Viterbo MD
Minimally Invasive Surgery, Infections & Inflammation, Surgical Oncology
Urologic Oncologist, Professor at Fox Chase Cancer Center/ TUH
Join to View Full Profile
333 Cottman AvenuePhiladelphia, PA 19111
Phone+1 215-728-6900
Dr. Viterbo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rosalia Viterbo is a Philadelphia-based Urologist specializing in minimally invasive surgery, infections and inflammation, and surgical oncology. She completed her medical education at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo and her residencies and fellowship at Temple University Hospital and City of Hope National Medical Center. Dr. Viterbo is the Urologic oncologist and an Associate Professor at Temple University Health System. Her experience spans prostate cancer, gynecologic oncology, urologic oncology, to name a few. Dr. Viterbo has been recognized with honors, such as the CMS Meaningful Use Stage 1 Certification and a fellowship from the American College of Surgeons. She also has an active academic career with several peer-reviewed publications to her credit.
Education & Training
City of Hope National Medical CenterFellowship, Complex General Surgical Oncology, 2006 - 2007
Temple University HospitalResidency, Urology, 2002 - 2006- Temple University HospitalResidency, Surgery, 2000 - 2002
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2000
Certifications & Licensure
CA State Medical License 2006 - Present
PA State Medical License 2001 - 2026
NJ State Medical License 2023 - 2025
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).Daniel M Geynisman, Philip H Abbosh, Eric Ross, Matthew R Zibelman, Pooja Ghatalia
Journal of Clinical Oncology. 2025-03-20 - A Randomized, Controlled Trial Evaluating Perioperative Risk-stratification and Risk-based, Protocol-driven Management After Elective Major Cancer Surgery.Nestor F Esnaola, Raju Chelluri, Jason Castellanos, Ariella Altman, David Y T Chen
Annals of Surgery. 2025-03-01 - 2 citationsSymptomatic and functional recovery after transurethral resection of bladder tumor: Data from ecological momentary symptom assessment.Marshall Strother, Ryan Barlotta, Robert Uzzo, Evan Bloom, Seyed B Jazayeri
Urologic Oncology. 2024-04-01
Journal Articles
- Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid FeaturesRichard E Greenberg, Rosalia Viterbo, Timothy Ito, Marc C Smaldone, Joseph R Testa, Philip H Abbosh, Robert G Uzzo, Alexander Kutikov, The Journal of Urology
Press Mentions
Better Robotic RP Skills Linked to Better ResultsJuly 14th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
